Breast Cancer

How do we define how we feel and answer the question, "How do you feel?"

Angela Schmidt Fishbaugh talks about being diagnosed with breast cancer after a mastectomy, changing her from a previvor to survivor.

Adding Perjeta (pertuzumab) to postoperative Herceptin (trastuzumab) improved survival in certain patients with breast cancer.

Alan Blassberg, Director/Producer of Pink and Blue: Colors of Hereditary Cancer, discusses being a male BRCA carrier.

Sharon Bober, PhD, discusses how patients can ask their doctors about sexual health.

Those considering mastectomy to help prevent inherited breast cancer, or because they’ve been diagnosed with the disease, are likely to find themselves sorting through a host of complex questions.

“This is the first phase 3 study to show an advantage of a PARP inhibitor over standard of care chemotherapy in breast cancer patients with a BRCA mutation,” said principal OLYMPIAD investigator Mark E. Robson, M.D., Clinic Director of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center.

The program XRAYS is a resource to help patients, survivors and their loved ones make sense of the articles on hereditary cancer they see in the mainstream media and via social media platforms.

Self-esteem and body image suffer after a breast cancer diagnosis. Finding a way to move past the trauma is challenging for some.

Chemobrain is more than being lazy or forgetful sometimes.

Becoming pregnant does not increase a woman's chance of having her breast cancer recur, according to a recent study presented at ASCO.

A recent clinical trial showed that psychological intervention can ease patients' anxiety and fear of recurrence.

Progression-free survival was improved for postmenopausal women with HER2-negative advanced breast cancer when treated with Kisqali plus letrozole.

The fear of metastatic cancer is a constant challenge. Even years after an initial diagnosis, cancer can return.

Recovering from breast cancer is a difficult time and can take the rest of your life, but it's important to fight for good health.

A male breast cancer survivor discovers this path to tranquility.

In the midst of the uncertainties of metastatic cancer, plans for treatment are the easy part. How to plan for life? That's more difficult.

Kari B. Wisinski, M.D., talks about new agents being explored in triple-negative breast cancer.

The Oncologic Drugs Advisory Committee (ODAC) recommended the approval of Nerlynx (neratinib) for some patients with breast cancer.

Early results for a new agent, pyrotinib (HTI-1001), are showing promise for the treatment of HER2-positive breast cancer, according to phase 1 results from China published in the Journal of Clinical Oncology, which showed that the drug was well-tolerated and showed anti-tumor activity.

Amye J. Tevaarwerk, M.D., discusses which patients with ER-positive breast cancer may be good candidates to continue endocrine therapy after five years.

A recent study found that the Chinese exercise method of tai chi can help combat insomnia in breast cancer survivors.

Are you deciding with your heart or with your head?

After the Affordable Care Act was passed, a study found that there were more stage 1 cancer diagnoses across the nation.

Post-mastectomy syndrome is a condition affecting some women after surgery for breast cancer. This syndrome occurs as nerves begin to regenerate and heal.